128 related articles for article (PubMed ID: 9360838)
1. Clonal origin of multiple lung cancers: K-ras and p53 mutations determined by nonradioisotopic single-strand conformation polymorphism analysis.
Lau DH; Yang B; Hu R; Benfield JR
Diagn Mol Pathol; 1997 Aug; 6(4):179-84. PubMed ID: 9360838
[TBL] [Abstract][Full Text] [Related]
2. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
3. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.
Koness RJ; King TC; Schechter S; McLean SF; Lodowsky C; Wanebo HJ
Ann Surg Oncol; 1996 Mar; 3(2):136-43. PubMed ID: 8646513
[TBL] [Abstract][Full Text] [Related]
4. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
[TBL] [Abstract][Full Text] [Related]
6. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers.
Mitsudomi T; Yatabe Y; Koshikawa T; Hatooka S; Shinoda M; Suyama M; Sugiura T; Ogawa M; Takahashi T
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):354-60. PubMed ID: 9305187
[TBL] [Abstract][Full Text] [Related]
8. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
10. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
Yamashita K; Yoshida T; Shinoda H; Okayasu I
Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
[TBL] [Abstract][Full Text] [Related]
11. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing].
Fang Q; Li X; Li J; Liang S
Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630
[TBL] [Abstract][Full Text] [Related]
12. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ
Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782
[TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.
Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J
Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050
[TBL] [Abstract][Full Text] [Related]
14. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
16. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
[TBL] [Abstract][Full Text] [Related]
17. Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups.
Kashii T; Mizushima Y; Lima CE; Noto H; Sato H; Saito H; Kusajima Y; Kitagawa M; Yamamoto K; Kobayashi M
Oncology; 1995; 52(3):219-25. PubMed ID: 7715905
[TBL] [Abstract][Full Text] [Related]
18. Distribution of p53 and K-ras mutations in human lung cancer tissues.
Gao HG; Chen JK; Stewart J; Song B; Rayappa C; Whong WZ; Ong T
Carcinogenesis; 1997 Mar; 18(3):473-8. PubMed ID: 9067544
[TBL] [Abstract][Full Text] [Related]
19. [Detection of p53 gene mutation in paraffin-embedded asbestos-related lung cancer tissue].
Fu D; Liu B; Wang H
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Jul; 31(4):206-8. PubMed ID: 9812577
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
